Oregon SB 764: Relating to agreements that lead to anticompetitive behavior in the market for pharmaceutical drugs.

Status: In committee upon adjournment. (as of 2021-06-27)

State: Oregon · Session: 2021 Regular Session · Bill: SB 764

Sponsors: Deb Patterson, Kim Wallan, Zach Hudson, Andrea Salinas, Bobby Levy, Chris Gorsek, Courtney Neron, Dacia Grayber, Elizabeth Steiner Hayward, Jeff Golden, Kate Lieber, Maxine Dexter, Rob Nosse, Sheri Schouten, Tawna Sanchez, Teresa Alonso Leon, Wlnsvey Campos

View Oregon SB 764 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.